NMN human trial results published

By Steve Hill | Lifespan

The data from a multicenter NMN clinical trial have been published with some very modest but still interesting results [1].

What is NMN?
NMN is short for nicotinamide mononucleotide, a naturally occurring molecule present in all species. It is a precursor of nicotinamide adenine dinucleotide (NAD+), a molecule that may be useful in slowing down some aspects of aging. NAD+ serves many critical functions in our cells, such as electron transport, cell signaling, facilitating cellular energy production, and DNA repair.

A growing amount of evidence suggests that as we age, our levels of NAD+ decline, increasing our risk of age-related diseases. This is why some researchers have proposed that restoring NAD+ levels in older people could help to slow down aging and keep them healthy.

READ ON:

Share this!

Additional Articles

Peoria’s economic outlook

By Alicia Venter | Peoria Times Peoria’s Fiscal Year 2024 Annual Comprehensive Financial Report was released last month, revealing the city’s positive economic outlook.  The

Read More »
News Categories

Get Our Twice Weekly Newsletter!

* indicates required

Rose Law Group pc values “outrageous client service.” We pride ourselves on hyper-responsiveness to our clients’ needs and an extraordinary record of success in achieving our clients’ goals. We know we get results and our list of outstanding clients speaks to the quality of our work.